Intellia Therapeutics (NTLA) Selling, General & Administrative (2015 - 2026)
Intellia Therapeutics (NTLA) posted Selling, General & Administrative of $37.82 million for Q2 2026, up 39.0% from $27.21 million a year earlier and up 8.6% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Selling, General & Administrative (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Intellia Therapeutics was $136.25 million, up 14.3% year-over-year; for FY2025, it came in at $119.8 million, down 4.8% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
- In prior years, Intellia Therapeutics' Selling, General & Administrative was $125.83 million in FY2024 (+8.0%), $116.5 million in FY2023 (+29.0%), $90.31 million in FY2022 (+27.0%) and $71.1 million in FY2021 (+61.0%).
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2015.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last three quarters, with growth averaging 7.0% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 105.4%; the weakest was Q2 2025, with a decline of 14.4%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $34.84 million (Q1 2026), $33.08 million (Q4 2025) and $30.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Intellia Therapeutics | 1.70 Bn | 1.70 Bn | - | 37.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.82 Mn |
| Mar 31, 2026 | 34.84 Mn |
| Dec 31, 2025 | 33.08 Mn |
| Sep 30, 2025 | 30.51 Mn |
| Jun 30, 2025 | 27.21 Mn |
| Mar 31, 2025 | 29.01 Mn |
| Dec 31, 2024 | 32.44 Mn |
| Sep 30, 2024 | 30.50 Mn |
| Jun 30, 2024 | 31.79 Mn |
| Mar 31, 2024 | 31.09 Mn |
| Dec 31, 2023 | 28.99 Mn |
| Sep 30, 2023 | 29.40 Mn |
| Jun 30, 2023 | 30.65 Mn |
| Mar 31, 2023 | 27.45 Mn |
| Dec 31, 2022 | 23.63 Mn |
| Sep 30, 2022 | 22.15 Mn |
| Jun 30, 2022 | 22.13 Mn |
| Mar 31, 2022 | 22.40 Mn |
| Dec 31, 2021 | 22.11 Mn |
| Sep 30, 2021 | 18.71 Mn |
API Access
Intellia Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();